Welcome to our dedicated page for Unitedhealth Gp news (Ticker: UNH), a resource for investors and traders seeking the latest updates and insights on Unitedhealth Gp stock.
UnitedHealth Group Incorporated reports developments across its UnitedHealthcare health coverage business and Optum health services operations. Recurring updates include health plan administration, prior authorization simplification, electronic submission standards, care-management practices and initiatives aimed at reducing administrative friction for members and care providers.
Company news also covers UnitedHealthcare community and provider collaborations, including rural care support, maternal health access, housing-related health programs for older adults and member navigation tools. Product and service updates include digital health capabilities such as the generative AI companion Avery, along with broader disclosures about transparency, accountability and the company’s role in medical benefits, clinical services, pharmacy services, data and health care analytics.
UnitedHealth Group (NYSE: UNH) reported results from its 2026 annual shareholder meeting and a new dividend.
Shareholders re-elected all current directors, approved the advisory vote on executive compensation, and ratified Deloitte & Touche LLP as independent auditor. A proposal for an independent Board Chair was not approved. The Board declared a $2.32 per-share cash dividend, payable June 23, 2026, to shareholders of record on June 15, 2026.
UnitedHealthcare (NYSE: UNH) will remove nearly two-thirds of prior authorization requirements for members under 18 by year-end 2026. The change covers many diagnostic, surgical and specialty pediatric services and adds waivers at leading pediatric hospitals.
It complements a 30% prior authorization reduction target for 2026, a transparent Optum Rx pharmacy pricing model, expanded support for about 1,500 rural hospitals, broader doula coverage for up to 7.2 million members by Jan. 1, 2027, and a pledge to rebate any 2026 profits from individual ACA plans.
UnitedHealthcare (NYSE:UNH) announced that UnitedHealthcare Community Plan of D.C. earned the NCQA Long-Term Services and Supports (LTSS) Distinction, recognizing person-centered, standardized management of long-term care.
The plan serves over 120,000 members in Washington, D.C., with 12 hospitals and 8,700+ providers, and supports seniors via a Housing Stabilization Fund collaboration.
UnitedHealthcare Community Plan of Idaho (NYSE:UNH) is providing more than $425,000 to support organizations statewide that address social barriers to health such as food access, transportation, and family support.
Funds back programs for families, seniors, pregnant women, children, Tribal communities and rural residents across Idaho.
Optum Rx (NYSE:UNH) introduced a transparent, fee‑based pharmacy care model that replaces pricing tied to drug list prices or prescription volume. Clients pay clearly defined monthly per‑member fees, with full visibility into Optum Rx and GPO fees and manufacturer payments, eliminating spread pricing.
The company is also launching Shop MyScript and Price Wise tools so consumers can compare options and see all‑in medication costs before filling prescriptions. Optum Rx highlights earlier actions, including a commitment to pass through 100% of manufacturer rebates by Jan. 1, 2028 and reductions in certain prior authorizations.
UnitedHealthcare (NYSE: UNH) will eliminate prior authorization requirements for 30% of services and intends to cut an additional 30% of remaining prior authorizations by the end of 2026. Changes include select outpatient surgeries, some diagnostic tests (eg, echocardiograms), outpatient therapies and chiropractic care.
The company says about 92% of submitted authorizations are approved in under 24 hours today, and that more than 70% of prior authorizations will use a standardized electronic submission process by year-end 2026. The rural exemptions program will expand to roughly 1,500 rural hospitals including all Critical Access Hospitals by fall 2026.
WEX (NYSE: C) and Impactive Capital reached a cooperation agreement to present a refreshed slate of 11 director nominees for the 2026 Annual Meeting, including three new independent directors: Kurt Adams, Ellen Alemany, and Lauren Taylor Wolfe. The Annual Meeting is rescheduled to May 14, 2026.
The company will separate the roles of Chair and CEO after the meeting; Melissa Smith will remain CEO and president. Impactive withdrew its separate nomination and agreed to support the revised slate; customary standstill, non-disparagement, and voting commitments apply.
UnitedHealthcare (NYSE:UNH) released findings from its fourth annual Young Adult & College Student Behavioral Health Report (April 28, 2026) showing sustained high prevalence of mental and behavioral health concerns among young adults and college students.
The survey found 62% reported a personal or peer concern in the past year; college students reported 69% versus 54% for nonstudents. Digital tools are rising: 31% used AI platforms and 26% sought companionship or reassurance from them. Cost is a barrier for 25% who did not seek help. UnitedHealthcare outlines behavioral health resources and navigation tools for students and families.
UnitedHealthcare (NYSE: UNH) will standardize electronic prior authorization submissions for more than half its prior authorization volume immediately and expects that to exceed 70% by year-end 2026. The standardized process will cover commercial, Medicare Advantage and Medicaid lines and aims to reduce rework, speed decisions and preserve clinical safeguards.
The initiative builds on prior industry commitments, the Gold Card program and digital tools for real-time tracking, with further service expansions planned over the coming months.
UnitedHealth Group (NYSE: UNH) reported Q1 2026 results: revenues $111.7B (+2% YoY), earnings $6.90/sh and adjusted earnings $7.23/sh. The company raised full‑year outlook to >$17.35 GAAP and >$18.25 adjusted, announced a ≥$2.0B buyback and closed the sale of Optum UK.
Medical care ratio improved to 83.9% (‑90 bps), operating cost ratio rose to 13.8% (+140 bps), cash from operations $8.9B, debt‑to‑capital 42.9%.